| Michelle Paik, RPH | |
|
400 S Randall Rd, Algonquin, IL 60102-9723 | |
| (847) 960-7810 | |
| Not Available |
| Full Name | Michelle Paik |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 400 S Randall Rd, Algonquin, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629609383 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1925840 (Wisconsin) | Secondary |
| 183500000X | Pharmacist | 051300928 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Paik, RPH 400 S Randall Rd, Algonquin, IL 60102-9723 Ph: () - | Michelle Paik, RPH 400 S Randall Rd, Algonquin, IL 60102-9723 Ph: (847) 960-7810 |
News Archive
TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).
In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy.
Renal denervation improves blood pressure and arterial stiffness in patients with therapy resistant hypertension, according to research presented at ESC Congress 2012 by Mr Klaas Franzen from the University Hospital of Schleswig-Holstein.
Concert Pharmaceuticals, Inc. announced today that it has initiated a Phase I study in healthy volunteers to evaluate the safety, tolerability and pharmacokinetics of CTP-347, a novel deuterium-containing serotonin modulator created by Concert researchers.
At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation, today announced that they have signed a memorandum of understanding (MOU) for the development of Magnetic Particle Imaging (MPI) scanners, a new imaging technology, for the preclinical market.
› Verified 7 days ago
Ms. Patricia L Briick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102 Phone: 224-569-2582 | |
Margeurite Sue Darguzis Thomas, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 E Algonquin Rd, Algonquin, IL 60102 Phone: 847-658-4036 | |
Dr. Kenneth K Phu, PHARMA-D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 S Randall Rd, Algonquin, IL 60102 Phone: 847-458-5341 Fax: 847-458-5341 | |
Peter Koch, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1501 E Algonquin Rd, Algonquin, IL 60102 Phone: 847-658-4032 | |
Jolanta Grys, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 107 S Randall Rd, Algonquin, IL 60102 Phone: 847-854-8274 Fax: 847-854-5302 | |
Dr. Anna Ciukaj, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102 Phone: 224-569-2582 | |
Mrs. Sapana Patel, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4001 W Algonquin Rd, Algonquin, IL 60102 Phone: 224-569-2582 |